Rx Regenerative Biopharmaceuticals

A next generation umbilical cord-derived mononuclear cell product exclusively produced following FDA cGMP regulations. Stem cell regenerative medicine has been an effective therapy for over ten years. However, little has changed in that time. Our recently developed innovative techniques maximize cell viability, which enhances mesenchymal stem cell (MSC) function and growth factor preservation. Our cell product is obtained from fresh, healthy, donated neonatal tissue and minimally manipulated to yield unprecedented viability.

It is an umbilical cord blood-derived cellular product containing mesenchymal Stem Cells (MSCs). In addition, this product contains UCB-derived mononuclear cells, which perform several important functions. First, these cells protect stem cells from the harsh environment of an inflamed joint or injured tissue. In addition, these mononuclear cells include immune progenitor cells that help modulate the local immune response itself.

All products are harvested from pre-screened, full term, c-section donor mothers. It is available in two cellular configurations; 10M cells and 25M cells, all products maintain in excess of 65% cell viability post thaw.

Cord blood, or umbilical cord blood, is the remaining blood from the placenta and umbilical cord after child birth. It is safe for the mother and baby because cord blood is typically collected after a baby is delivered and the cord is cut. The composition of cord blood contains all the elements found in whole blood such as red blood cells, white blood cells, plasma, platelets and hematopoietic stem cells. Stems cells that are derived from cord blood can be used to treat hematopoietic and genetic disorders.

They can also be utilized similarly to hematopoietic stem cell transplantation to reconstitute bone marrow following radiation treatment for various forms of blood cancers and anemia. To produce healthy new blood cells and boost the immune system, stem cells from cord blood can replenish the body’s supply of blood cells. This is beneficial for not just blood cancers such as leukemia and lymphoma, sickle cell, and Wiskott-Aldrich syndrome, but also radiation and chemotherapy treatments that could deplete many helpful blood cells along with harmful tumors or cells.

Under regulation by the FDA, it is simple to safely collect, cryopreserve, and use in hematopoietic stem cell transplantation. With public and private banks ensuring that cord blood stored is safe and effective for patients, it has the integrity and support needed to be utilized to its fullest in the regeneration and re-growth of blood-forming cells. There are many studies showing the incredible regenerative capabilities of cord blood within application to orthopedic indications, additional studies are available demonstrating a diverse use of this mesenchymal cell rich product.